Cussac C, Riviere P, Altwegg R, Caillo L, et al. Safety of Advanced Combination Treatment With Selective JAK1 Inhibitors and Biological Therapies in Inflammatory Bowel Diseases: A Real World Experience. Aliment Pharmacol Ther 2025;61:1692-1696.
PMID: 40047405